Increased RNA Degradation [PE] - N0000194154

Name: Table of NDC products with increased rna degradation
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000194154
Pharmacologic Name	Increased RNA Degradation
Pharmacologic Uses	antithrombin-directed small interfering ribonucleic acid APOC-III-directed antisense oligonucleotide (ASO)
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased RNA Degradation

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Increased RNA Degradation [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	58468-0347	Qfitlia	Non-Proprietary Name: Fitusiran	Injection, Solution	Subcutaneous	Genzyme Corporation	ACTIVE
	58468-0348	Qfitlia	Non-Proprietary Name: Fitusiran	Injection, Solution	Subcutaneous	Genzyme Corporation	ACTIVE